Skip to content

InnovAge Holdings, Inc. INNV All other — External provider costs

Other segment segments

PACE
$113.25M+5.0%

Similar metrics at other companies

Envista Holdings Corporation logo
NVSTOther — Costs incurred
$400K-89.5%
Amplitude, Inc. logo
AMPLAll Other Segments — Other Expenses
$21.02M-4.8%
Navient logo
NAVIAll Other Segments — Other Expenses
$3M-40.0%
Fulton Financial logo
FULTOther outside services
$12.75M+7.7%
Ameresco logo
AMRCAll Other — Cost of revenues
$9.46M-7.2%
NBT
NBTBAll Other Segments — Professional Fees
-$376K-2.5%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.31B+150%
Enterprise value$1.31B+130%
P/S1.4×+0.7×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept innv:ExternalProviderCosts.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s all other — external provider costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s all other — external provider costs?
InnovAge Holdings, Inc. (INNV) reported all other — external provider costs of $0 in Q1 2026.
What does all other — external provider costs mean?
This metric measures the expenses paid to third-party healthcare providers for services rendered to patients within the 'All other' business segment. Monitoring these costs is essential for evaluating the segment's reliance on external networks versus internal care delivery capabilities.